Mayo Clinic Finds Tool to Predict Disability Timeline for Progressive MS Patients

	Tweet

Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence of certain markers in a commonly performed diagnostic test, Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety. The research is being presented at the American Academy of Neurology meeting in Honolulu, Hawaii.

Progressive MS is a disease of the central nervous system that can damage the brain, spinal cord and optic nerves. Over time, this damage can make it difficult or impossible for patients to walk, making them reliant on mobility aids such as walkers or wheelchairs.

“In this study, we found that in patients who developed the progressive form of MS that had preceding relapses, the presence of greater production of one of these molecules, immunoglobulin G, predicted a faster onset of disability,” explains Orhun Kantarci, M.D., a Mayo Clinic neurologist and the study’s lead author. As physicians better predict the onset of disability, they can better counsel patients by providing answers in a time of uncertainty.

The study looked at cerebrospinal fluid (CSF) test results from a sample of 281 progressive MS patients seen at Mayo Clinic from 2002 to 2007. In general, CSF test results help physicians when the diagnosis is uncertain. For this study, researchers analyzed CSF test results and noticed a relationship between a faster disability rate and abnormally high levels of two proteins — oligoclonal band and immunoglobulin-G molecule. If patients had the progressive form of MS with proceeding relapses, and their CSF results showed an elevated protein, researchers concluded they will have a faster rate of disability.

The study is a significant step forward in predicting disability outcomes, says researcher Junger Tang, M.D., a neurology fellow at Mayo Clinic. The next step is further research to confirm the results, he says.

MS is the most common cause of nontraumatic neurological disability in young adults in North America and Europe. MS occurs most often in people ages 20 to 40, and is up to three times more common in women than men. Symptoms include weakness, loss of sensation, visual disturbances, and cognitive dysfunction.

###
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life.

###

ROCHESTER, Minn
Mayo Foundation for Medical Education and Research

RELATED STORIES:
New data demonstrate potential for early detection of Alzheimer’s disease   Experiments point to new way to combat Alzheimer’s   Coffee drinkers show lower dementia risk   For nutrition info, moms like the Web best   Moderate drinking may not preserve thinking skills   Find Yields Further Insight Into Causes of Parkinson’s Disease   New X-ray method for understanding brain disorders better   Link Between Gastric Bypass Surgery and Neurological Conditions   Hormone Shows Promise in Reversing Alzheimer’s and Stroke   Stroke study sheds light on left-right brain divide   Predicting risk of stroke from one’s genetic blueprint   Alzheimer’s drug may help with Parkinson’s too

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]